“Fortis Healthcare Acquires Stake in Agilus Diagnostics: Stock Market News Updates – December 20, 2024”

In a major development in the healthcare sector, Fortis Healthcare has acquired a 7.61% stake in Agilus Diagnostics for a whopping ₹429.37 crore. This acquisition is set to significantly strengthen Fortis Healthcare’s position in the diagnostics industry and expand its range of services.

The deal, which was finalized on December 20, 2024, marks a strategic move for Fortis Healthcare as it looks to diversify its portfolio and tap into the growing demand for diagnostic services in the country. Agilus Diagnostics is known for its cutting-edge technology and innovative approach to diagnostics, making it a valuable addition to Fortis Healthcare’s network.

Investors and industry experts are closely watching this development, as it signals Fortis Healthcare’s aggressive expansion strategy and its commitment to staying ahead in the competitive healthcare market. The stock market is expected to react positively to this news, with Fortis Healthcare’s shares likely to see a boost in the coming days.

Overall, this acquisition is a significant milestone for Fortis Healthcare and is expected to have a positive impact on its growth trajectory in the years to come. Stay tuned for more updates on this story as it unfolds.